Programmable Stapling Peptide Based on Sulfonium as Universal Vaccine Adjuvants for Multiple Types of Vaccines
Advanced Science · 2025
DOI: 10.1002/advs.202409567 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Yaping Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, 51…. Hauptthemen laut MEDLINE: Peptides, Adjuvants, Immunologic, Adjuvants, Vaccine, Vaccines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Center for Biological Medicine Technology Innovation, Natural Science Foundation of China.
Abstract (Originalsprache)
Adjuvants are non‐specific immune enhancers commonly used to improve the responsiveness and persistence of the immune system toward antigens. However, due to the undefined chemical structure, toxicity, non‐biodegradability, and lack of design technology in many existing adjuvants, it remains difficult to achieve substantive breakthroughs in the adjuvant research field. Here, a novel adjuvant development strategy based on stapling peptides is reported to overcome this challenge. The nano‐vaccine incorporating peptide adjuvant and recombinant HBsAg protein not only induced strong antibody titers that are equivalent to aluminum adjuvanted vaccines but also simultaneously activated T‐cell immune response. Similar results are also observed in herpes zoster vaccine and more complex influenza vaccine. The mechanism analysis demonstrates that antigen is efficiently carried into antigen‐presenting cells (APCs) by peptide, further promoting the secretion of cytokines and activation of APCs. In addition, by redesigning the adjuvant, it is found that the sulfonium centers, rather than the sequence of peptide played an important role in immune activation. This discovery may provide a new paradigm for the rational design of peptide‐based adjuvants. In brief, this study demonstrates that stapling peptides with sulfonium centers can provide a well‐defined, programmable, biocompatible, and effective adjuvant for multiple types of vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, 518055, P. R. China.
- Pingshan Translational Medicine Center, Shenzhen Bay Laboratory, Shenzhen, 518118, P. R. China.
- Shenzhen Kangtai Biological Products Co. Ltd., Shenzhen, 518057, P. R. China.
- Beijing Minhai Biotechnology Co. Ltd., Beijing, 102609, P. R. China.
Förderung
- National Key R&D Program of China
- National Center for Biological Medicine Technology Innovation
- Natural Science Foundation of China
- Shenzhen Science and Technology Program
- High-tech Zone Development Special Project of Shenzhen
- Tian Fu Jin Cheng Laboratory (Advanced Medical Center) Group Racing Project
- Beijing National Laboratory of Molecular Science
- Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions
Zitieren
APA
Zhang, Y., Lian, C., Lai, W., Jiang, L., Xing, Y., Liang, H., Li, J., Zhang, X., Gan, J., Li, Z., & Yin, F. (2025). Programmable Stapling Peptide Based on Sulfonium as Universal Vaccine Adjuvants for Multiple Types of Vaccines. Advanced Science. https://doi.org/10.1002/advs.202409567
Vancouver
Zhang Y, Lian C, Lai W, Jiang L, Xing Y, Liang H, et al. Programmable Stapling Peptide Based on Sulfonium as Universal Vaccine Adjuvants for Multiple Types of Vaccines. Advanced Science. 2025. doi:10.1002/advs.202409567
BibTeX
@article{Zhang2025,
author = {Zhang, Yaping and Lian, Chenshan and Lai, Wenlong and Jiang, Leying and Xing, Yun and Liang, Huiting and Li, Jin and Zhang, Xinming and Gan, Jianhui and Li, Zigang and Yin, Feng},
title = {Programmable Stapling Peptide Based on Sulfonium as Universal Vaccine Adjuvants for Multiple Types of Vaccines},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202409567}
}
EUVIMED